(Q77478764)
Statements
Continuous interleukin-2 infusion combined with cyclophosphamide- based combination chemotherapy in the treatment of hemato-oncological malignancies. Results of a phase I-II study (English)
A Nagler
A Ackerstein
M Ben-Shahar
R Or
E Naparstek
R Ben-Yosef